OVERVIEW

BUSINESS REVIEW, PROSPECTS AND FUTURE PLAN

 

  Since early 2020, the outbreak of Coronavirus Disease 2019 (the “COVID-19”) has spread throughout the world. Every countries had implemented different levels of disease prevention measures, including lockdown and quarantine policies.

 

  Hong Kong suffered the fourth wave of the COVID-19 ending in May 2021 and entered the fifth wave of the COVID-19 in January 2022, certain prevention measures have been implementing. Two years have passed, daily coronavirus cases in certain countries still closed to record high.

 

  The COVID-19 definitely impacted to Hong Kong, China and even the global economy. The Hang Seng Index fell 14 per cent in 2021, making Hong Kong the worst performing market out of 92 major indexes tracked by Bloomberg. Only Hang Seng China Enterprises Index fared worse, fell 23.3 per cent in 2021. As a result, the Group suffered net loss for the Reporting Period.

 

  The external environment is of high relevance to the economy and financial market in Hong Kong. In term of the COVID-19 still raging across the world, the Group expects it will continue to affect the Group’s financial performance. The Group will closely monitor the development of the COVID-19 outbreak and continue to evaluate its impact on our business, financial position and operating results.

 

  Looking ahead to the year 2022, the Company will stay in focus to invest in trading securities, private equity funds and private enterprises with potential prospect. Our approach will keep timely and appropriate investment strategies in response to the volatile market, in order to enhance our investment portfolio and achieve net asset appreciation. The Board will pay close attention to the macro trends and keep seeking opportunities to invest in China, Hong Kong and overseas. The Company will continue to implement its risk management policy with an aim to achieve stable returns on investments for our shareholders.